10.20DKK-4.67%Mkt Cap: 94.68M DKKP/E: —Last update: 2026-06-01
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidime…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap94.68M DKK
Enterprise Value81.26M DKK
Revenue (TTM)9.01M DKK
Gross Profit6.62M DKK
Net Income (TTM)-10.40M DKK
Revenue/Share0.9700 DKK
Last Price10.20 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountryDK
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue9.02
P/S11.03
P/B29.16
EPS (TTM)-1.24
EPS (Forward)—
52W Range
7.40028% of range17.40
52W High17.40 DKK
52W Low7.400 DKK
Profitability
Gross Margin74.36%
Oper. Margin-220.26%
EBITDA Margin0.00%
Profit Margin-116.77%
ROE-53.58%
ROA-33.99%
Growth
Revenue Growth8.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.13M DKK
CapEx (TTM)—
FCF Margin-40.77%
FCF Yield-3.88%
Net Debt-18.06M DKK
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.24
Current Ratio3.82
Quick Ratio3.50
Book Value/Sh0.3670 DKK
Cash/Share2.400 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.28M
Float2.37M
Insiders56.66%
Institutions0.00%
Technical
SMA 5010.83 (-5.8%)
SMA 20011.87 (-14.1%)
Beta0.65
S&P 52W Chg27.94%
Avg Vol (30d)860
Avg Vol (10d)1.28K
Technical Indicators
RSI (14)49.7
MACD-0.0594
MACD Signal-0.0941
MACD Hist.+0.0347
BB Upper11.39 DKK
BB Middle10.58 DKK
BB Lower9.771 DKK
BB Width15.30%
ATR (14)0.5885 DKK
Vol Ratio (20d)0.91x